Does disease activity at start of biologic therapy influence work-loss in RA patients?

Tor O Olofsson, Kari Johansson, Jonas K Eriksson, Ronald van Vollenhoven, Heather Miller, Ingemar Petersson, Johan Askling, Martin Neovius

Research output: Contribution to journalArticlepeer-review

Abstract

To compare work-loss in RA patients starting their first biologic with high vs moderate disease activity.
Original languageEnglish
JournalRheumatology (Oxford, England)
Early online date2015 Dec 18
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Rheumatology and Autoimmunity

Fingerprint

Dive into the research topics of 'Does disease activity at start of biologic therapy influence work-loss in RA patients?'. Together they form a unique fingerprint.

Cite this